AI-generated summary
The authors report a scoping review of low-level laser therapy for skin and mucosal lesions in epidermolysis bullosa, searching PubMed, Scielo and Lilacs. No randomized or controlled clinical trials were found, and the four included studies suggested possible benefits for healing and pain reduction. The authors describe LLLT as a potentially adjuvant therapy, but the included evidence is limited.
- Participants
- 7
- Studies included
- 4
- Who or what was studied
- Patients with epidermolysis bullosa with cutaneous or mucosal lesions
- Limits stated in the abstract
- No randomized or controlled trials were identified, so the included evidence consists of four studies of limited design.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.